Deferasirox Dispersable Tablets 500 mg

DEFROSIA 500 is a clinically trusted formulation containing Deferasirox Dispersible Tablets 500 mg, widely used for the management of chronic iron overload in patients undergoing frequent blood transfusions. Iron overload is a serious condition where excess iron accumulates in the body, potentially damaging vital organs such as the liver, heart, and endocrine glands. DEFROSIA 500 works as an effective iron chelating agent, helping remove excess iron from the bloodstream and maintaining healthy iron levels. Its dispersible tablet form ensures easy administration, especially for patients who may have difficulty swallowing conventional tablets.

Uses

DEFROSIA 500 is primarily prescribed for:

• Treatment of chronic iron overload caused by repeated blood transfusions (commonly seen in conditions like thalassemia and anemia)
• Management of non-transfusion-dependent iron overload syndromes
• Prevention of iron-related complications affecting organs such as the liver and heart

By binding excess iron and facilitating its removal through stool, this medicine helps reduce the toxic effects of iron accumulation in the body.

Benefits

DEFROSIA 500 offers multiple therapeutic advantages for patients suffering from iron overload:

• Effective Iron Removal: It binds to excess iron and promotes its elimination, reducing iron toxicity.
• Organ Protection: Helps prevent damage to vital organs like the liver and heart caused by iron deposition.
• Improved Quality of Life: Reduces symptoms such as fatigue, weakness, and organ dysfunction associated with iron overload.
• Convenient Dosage Form: Dispersible tablets can be dissolved in water, making it easier to consume, especially for pediatric and elderly patients.
• Long-Term Management: Suitable for prolonged use under medical supervision to maintain optimal iron levels.

Dosage

The dosage of DEFROSIA 500 should always be taken as prescribed by a healthcare professional. It depends on factors such as body weight, severity of iron overload, and patient response to therapy.

• Typically taken once daily on an empty stomach, at least 30 minutes before food
• The tablet should be dissolved in water or juice and consumed immediately
• Regular monitoring of serum ferritin levels is required to adjust the dose

Patients are advised not to skip doses or discontinue treatment without consulting their doctor, as consistent therapy is essential for effective iron control.

Side Effects

Like all medications, DEFROSIA 500 may cause some side effects, although not everyone experiences them. Common side effects include:

• Nausea and vomiting
• Abdominal pain
• Diarrhea
• Skin rash
• Headache

In rare cases, serious side effects may occur, such as:

• Kidney or liver dysfunction
• Hearing or vision disturbances
• Severe allergic reactions

If any unusual symptoms are observed, immediate medical attention is recommended.

Precautions and Warning

Before starting DEFROSIA 500, certain precautions should be considered to ensure safe and effective use:

• Medical History: Inform your doctor about any history of kidney, liver, or heart disease
• Regular Monitoring: Routine blood tests are necessary to monitor iron levels and organ function
• Pregnancy & Breastfeeding: Use only if prescribed, as safety data may be limited
• Drug Interactions: Inform your healthcare provider about all medications and supplements being taken
• Hydration: Maintain adequate fluid intake to support kidney function
• Avoid Overdose: Strictly follow the prescribed dosage to prevent toxicity

Patients should also report any symptoms such as decreased urine output, yellowing of the skin, or persistent fatigue, as these may indicate serious complications.

Conclusion

DEFROSIA 500 (Deferasirox Dispersible Tablets 500 mg) is a highly effective solution for managing chronic iron overload, especially in patients requiring frequent blood transfusions. With its proven ability to reduce excess iron and protect vital organs, it plays a crucial role in long-term patient care. The convenient dispersible form enhances patient compliance, making it suitable for a wide range of individuals. However, proper medical supervision, regular monitoring, and adherence to prescribed guidelines are essential to achieve the best therapeutic outcomes.